Nakayama Goro, Tanaka Chie, Kodera Yasuhiro
Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan.
Gastrointest Tumors. 2013 Sep;1(1):25-32. doi: 10.1159/000354995. Epub 2013 Sep 12.
Colorectal cancer (CRC) is the one of the most common malignancies and is a leading cause of cancer death worldwide. The incidence of mortality from CRC has decreased in Western countries because of earlier diagnosis and improved treatment modalities; however, mortality is still increasing in most other regions of the world.
Progress in the development of imaging modalities has enabled more accurate staging based on the TNM classification. The therapeutic management of CRC should involve a multi-modal approach, including high-quality surgery and an optimal choice of chemotherapy and radiotherapy regimens according to disease characteristics and patient preferences. Even in the case of metastatic disease, the optimal multi-modal treatments could achieve potential cure or long-term survival benefit in some patients. The aim of this review is to present current options regarding the diagnosis, staging and treatment management for CRC based on published research reports and the current management guidelines.
结直肠癌(CRC)是最常见的恶性肿瘤之一,也是全球癌症死亡的主要原因。在西方国家,由于早期诊断和治疗方式的改进,CRC的死亡率有所下降;然而,在世界其他大多数地区,死亡率仍在上升。
成像技术的发展进步使得基于TNM分类的分期更加准确。CRC的治疗管理应采用多模式方法,包括高质量的手术以及根据疾病特征和患者偏好优化选择化疗和放疗方案。即使是转移性疾病,最佳的多模式治疗也能使一些患者获得潜在治愈或长期生存益处。本综述的目的是根据已发表的研究报告和当前的管理指南,介绍CRC诊断、分期和治疗管理的当前选择。